The open source MySQL spin-off has steadily added features all its own. Here are five good reasons to switch to MariaDB.

Madrigal Pharmaceuticals (MASH) has reached an exclusive licensing agreement with China-based Suzhou Ribo Life Science to jointly develop treatments targeting a liver disease called metabolic ...

Targeted therapies for MASH show progress, with pegozafermin leading in efficacy for fibrosis regression and disease resolution. The lack of head-to-head trials complicates treatment prioritization, ...

The European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) has recommended granting conditional marketing authorization to semaglutide (Kayshild, Novo Nordisk) for ...

In May of 2025, MySQL celebrated its 30th anniversary. Not many technology projects go strong for three decades, let alone at the level of use that MySQL enjoys. MySQL is listed at #2 on the ...

This article originally appeared on HCPLive®. The FDA has granted breakthrough therapy designation (BTD) for pemvidutide for the treatment of metabolic dysfunction–associated steatohepatitis (MASH). 1 ...

Please provide your email address to receive an email when new articles are posted on . AIM-MASH AI Assist is the first AI drug development tool to be qualified by the FDA. The tool is designed to ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Cory Benfield discusses the evolution of ...